1. Home
  2. CLLS vs GDEV Comparison

CLLS vs GDEV Comparison

Compare CLLS & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • GDEV
  • Stock Information
  • Founded
  • CLLS 1999
  • GDEV 2009
  • Country
  • CLLS France
  • GDEV Cyprus
  • Employees
  • CLLS N/A
  • GDEV N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • GDEV EDP Services
  • Sector
  • CLLS Health Care
  • GDEV Technology
  • Exchange
  • CLLS Nasdaq
  • GDEV Nasdaq
  • Market Cap
  • CLLS 299.0M
  • GDEV 266.7M
  • IPO Year
  • CLLS 2007
  • GDEV N/A
  • Fundamental
  • Price
  • CLLS $2.85
  • GDEV $12.73
  • Analyst Decision
  • CLLS Buy
  • GDEV Buy
  • Analyst Count
  • CLLS 1
  • GDEV 1
  • Target Price
  • CLLS $4.00
  • GDEV $70.00
  • AVG Volume (30 Days)
  • CLLS 199.3K
  • GDEV 8.1K
  • Earning Date
  • CLLS 08-04-2025
  • GDEV 09-03-2025
  • Dividend Yield
  • CLLS N/A
  • GDEV N/A
  • EPS Growth
  • CLLS N/A
  • GDEV N/A
  • EPS
  • CLLS N/A
  • GDEV 1.38
  • Revenue
  • CLLS $63,438,000.00
  • GDEV $420,933,000.00
  • Revenue This Year
  • CLLS N/A
  • GDEV N/A
  • Revenue Next Year
  • CLLS $4.90
  • GDEV $11.69
  • P/E Ratio
  • CLLS N/A
  • GDEV $9.63
  • Revenue Growth
  • CLLS 223.09
  • GDEV N/A
  • 52 Week Low
  • CLLS $1.10
  • GDEV $8.60
  • 52 Week High
  • CLLS $3.24
  • GDEV $42.76
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 59.27
  • GDEV 38.89
  • Support Level
  • CLLS $2.71
  • GDEV $11.30
  • Resistance Level
  • CLLS $3.08
  • GDEV $14.86
  • Average True Range (ATR)
  • CLLS 0.20
  • GDEV 1.04
  • MACD
  • CLLS -0.03
  • GDEV -0.12
  • Stochastic Oscillator
  • CLLS 61.67
  • GDEV 30.89

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About GDEV GDEV Inc.

GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.

Share on Social Networks: